Intestinal nutrition market is expected to reach $ 10,478.0 million by 2025
The global nutritional nutrition market size is expected to reach $5,661.6 million in 2017, reaching $10,478.0 million in 2025, with an annual CAGR of 7.9% from 2018 to 2025. Patients who cannot swallow food or eat or drink enough nutrients. This medical device delivers drugs, nutrients directly to the stomach, duodenum, or plant through the nose, mouth, or direct transdermal routes.
Increased prevalence of multiple chronic disorders, such as cancer and nervous system disorders worldwide, a surge in the introduction of gut nutrients to parenteral nutrition, an increase in the elderly population, and growth in malnutrition cases drive market growth. However, strict government regulations leading to accidental disability and death and careless disposal of tubes hinder market growth. Conversely, the development of new products with fewer side effects and no market potential in emerging countries is expected to provide favorable growth opportunities for the intestinal nutrition market worldwide.
Click here to access the free sample report: https://www.alliedmarketresearch.com/request-sample/5049
According to WHO, the number of people diagnosed with diabetes increased from 180 million in 1980 to 428 million in 2014. In addition, the prevalence of diabetes in adults over the age of 18 increased from 4.7% in 1980 to 8.5% in 2014. This growth pattern is more evident in middle and low income countries. Therefore, the increased prevalence of diabetes promotes the growth of the intestinal nutrition market.
According to National Cancer Institute data, it is estimated that 1,735,350 new cancers will be diagnosed in the United States by the end of 2018. In addition, according to Centers for Disease Control and Prevention (CDC) data, all adults around the world (about 117 million people) suffer from one or more chronic health conditions in 2012, while diabetes is the most common chronic disease. Therefore, the rapidly growing cases of cancer worldwide are expected to increase the adoption of the intestinal feeding system, thereby promoting the growth of the intestinal nutrition market.
Worldwide, the elderly population vulnerable to disorders such as cardiovascular disease, stroke, diabetes, stomach disease and intestinal disease has increased tremendously in the past few years. According to data released by the U.S. Census Bureau, in 2015, about 670 million people worldwide were at age 65 or older. The number of elderly people is expected to increase by 60% in just 15 years, and is expected to increase further in the next 20 years. The rapid increase in nutrients in the elderly is one of the main driving forces in the intestinal nutrition market. This is because they are very vulnerable to various diseases caused by immunity and degeneration.
Intestinal nutrition is preferred over parenteral nutrition due to improved safety and ease of access. In addition, percutaneous conjunctivitis, percutaneous double ductal gastrectomy and the use of nasal incision are excellent safety. Therefore, due to the many advantages of intestinal feeding, it is very acceptable as a home feeding therapy.
Emerging economies in the Asia-Pacific region offer favorable growth opportunities for market players due to improved health care infrastructure and increased demand for better health care services in the region. Moreover, increasing prevalence of several chronic diseases in developing countries increases the demand for intestinal nutrition. In addition, growth in the intestinal nutrition market is expected to accelerate as medical spending in the region increases.
Digital marketing is preferred over traditional advertising methods due to the increasing penetration of the Internet and social media. Mobile apps and social media will play a decisive role in helping emerging markets like India to keep up with the technological advantage of competitors like China.
Indian pharmaceutical companies are beginning to invest in digital platforms for marketing. In 2016, India's multinational pharmaceutical company Sun Pharmaceuticals Industries Ltd. launched RespiTrack, a mobile app with features such as drug alerts, pre-programmed alerts, and over-the-air (OTA) reviews from doctors and others.
British pharmaceutical company GlaxoSmithKline plc equips its employees with iPads to provide real-time information on advances in the field of treatment. In addition, doctors drive sales using platforms such as webinars, video chats, information portals, and Viva.
Purchase Inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/5049
The main results of the enteral nutrition market:
• Protein for diabetes treatment patient segment by protein composition